Since PYK2 is a calcium-activated tyrosine kinase and enriches cancer stem cells by activating SRC-STAT3 signaling upon carboplatin treatment [32, 39], we decided to check whether cisplatin treatment-induced Lon activates the calcium-related PYK2-SRC-STAT3 pathway. This evidence concerns the gene SRC and cancer.